Golgi apparatus: New target for treatment of acute cerebral infarction

NewsGuard 100/100 Score

Expression of soluble CD40L has been shown to increase sig-nificantly in conditions such as stroke, myocardial infarction, unstable angina, high cholesterol, or other cardiovascular events. 95% of the circulating CD40L exists in activated platelets. However, the specific pathway of the transition of CD40L is not elucidated, and whether Golgi apparatus is involved in the expression of platelet CD40L still needs to be proven.

Dr. Wei Lu and colleagues from Second Xiangya Hospital, Central South University, found that platelet Golgi apparatus displayed significant morphological changes, which were possibly associated with enhanced synthetic and secretory functions of activated platelets after acute cerebral infarction. Golgi apparatus participated in the synthesis and transport of CD40L to the platelet surface, which may be a new target for the treatment of acute cerebral infarction. These findings were published in the Neural Regeneration Research (Vol. 8, No. 23, 2013).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel cholesterol removal strategy shows potential benefits post-heart attack